Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 377-383, August 2010

Dietary constituents of broccoli and other cruciferous vegetables: Implications for prevention and therapy of cancer

  • Ingrid Herr

      Affiliations

    • Molecular OncoSurgery, University of Heidelberg, German Cancer Research Center, Im Neuenheimer Feld 365, 69120 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6221 56 38354; fax: +49 6221 56 6119.
  • ,
  • Markus W. Büchler

      Affiliations

    • Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 150, 69120 Heidelberg, Germany

Received 8 October 2009; received in revised form 23 December 2009; accepted 17 January 2010. published online 22 February 2010.

Summary 

Over the past several decades, research on the action of bioactive constituents of plants has focused predominantly on their cancer-preventive properties. Today it can be explained why the consumption of fruits and vegetables may lead to a reduced frequency of certain cancer entities and why certain foods have therapeutic effects. Secondary plant products and especially glucosinolates from vegetables of the cruciferae family are supposed to have anti-carcinogenic potential. The present article gives an overview about secondary plant products in general and focuses to mechanisms of preventive and therapeutic effects of cruciferae, particular the brassica family and their famous member broccoli. Also, this article summarizes our knowledge of safety, tolerance and metabolism of glucosinolates and their therapeutic active degradation products isothiocyanates in animals and clinical studies.

Keywords: Secondary plant products, Cruciferae (brassiceae), Broccoli, Glucosinolate, Sulforaphane

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(10)00017-4

doi:10.1016/j.ctrv.2010.01.002

Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 377-383, August 2010